Eva Sonja Bender

Mrs. Eva Sonja Bender


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AKAikaterini Katramadou
Aikaterini Katramadou
EBEva Sonja Bender
Eva Sonja Bender
Dimitrios N. KanakisDimitrios N. Kanakis
Dimitrios N. Kanakis
Traumatic brain injury (TBI) is being increasingly recognized as a major risk factor for chronic neurodegenerative disease, including chronic traumatic encephalopathy (CTE) and Alzheimer’s disease (AD). Biomechanical forces during head trauma, particularly rotational acceleration and angular deformation, produce diffuse axonal injury (DAI) and widespread white matter damage that trigger persistent neurobiological cascades. These include axonal transport failure, blood–brain barrier (BBB) disruption, neuroinflammation, neurovascular and mitochondrial dysfunction, and pathological protein aggregation, closely paralleling core AD features. Epidemiological data support a dose–response relationship between TBI severity or repetition and subsequent dementia risk, moderated by genetic factors such as apolipoprotein E4 (ApoE4). Converging experimental and early clinical studies have begun to target shared injury and neurodegenerative pathways through acute neuroprotection, stem cell-based strategies for BBB restoration and neural repair, transcriptional and hormonal modulation, mitochondrial stabilization, and immunomodulation of chronic inflammation. This review synthesizes evidence linking biomechanical injury to molecular and neurovascular pathways of neurodegeneration and summarizes emerging temporally targeted interventions. By integrating mechanistic and therapeutic perspectives, we aim to narrow the translational gap between TBI and AD, refine identification of at-risk populations, and inform priorities for prevention and development of disease-modifying therapies.

13 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AKAikaterini Katramadou
Aikaterini Katramadou
EBEva Sonja Bender
Eva Sonja Bender
Dimitrios N. KanakisDimitrios N. Kanakis
Dimitrios N. Kanakis
Traumatic brain injury (TBI) is increasingly recognized as a major risk factor for chronic neurodegenerative disease, including chronic traumatic encephalopathy (CTE) and Alzheimer’s disease (AD). Biomechanical forces during head trauma, particularly rota-tional acceleration and angular deformation, produce diffuse axonal injury (DAI) and widespread white matter damage that trigger persistent neurobiological cascades. These include axonal transport failure, blood-brain barrier (BBB) disruption, neuroinflamma-tion, neurovascular and mitochondrial dysfunction, and pathological protein aggrega-tion, closely paralleling core features of AD. Epidemiological data support a dose-response relationship between TBI severity or repetition and subsequent dementia risk, moderated by genetic factors such as apolipoprotein E4 (ApoE4). Converging ex-perimental and early clinical studies have begun to target shared injury and neuro-degenerative pathways through acute neuroprotection, stem cell-based strategies for BBB restoration and neural repair, transcriptional and hormonal modulation, mitochondrial stabilization, and immunomodulation of chronic inflammation. This review systemati-cally synthesizes evidence linking biomechanical injury to molecular and neurovascular pathways of neurodegeneration, and summarizes emerging temporally targeted inter-ventions. By integrating mechanistic and therapeutic perspectives, we aim to narrow the translational gap between TBI and AD, refine identification of at-risk populations, and inform priorities for prevention and development of disease-modifying therapies.

14 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EBEva Sonja Bender
Eva Sonja Bender
AKAikaterini Katramadou
Aikaterini Katramadou
Dimitrios N. KanakisDimitrios N. Kanakis
Dimitrios N. Kanakis
Traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), and Alzheimer's disease (AD) share several neuropathophysiological mechanisms, including axonal injury, neuroinflammation, and abnormal protein aggregation, which may contribute to overlapping clinical manifestations. This review compares the clinical phenotypes of TBI, CTE, and AD across somatic and sensory, motor, cognitive, and neuropsychiatric domains to identify shared and distinguishing characteristics. Common manifestations include memory and attention deficits, executive dysfunction, slowed information processing, gait and balance impairment, depression, anxiety, irritability, apathy, and personality changes. Despite these similarities, important differences were identified. TBI presents acutely following injury and is associated with headache, vestibular disturbances, loss of consciousness, and post-traumatic amnesia. CTE typically develops years after repetitive head trauma and initially manifests with mood and behavioural disturbances, followed by progressive cognitive decline and dementia in advanced stages. AD is characterized by progressive episodic memory impairment, followed by language, visuospatial, executive, and functional decline. The overlap in clinical presentation, particularly between CTE and AD, may complicate differential diagnosis. Careful assessment of symptom onset, disease progression, injury history, neuropsychological findings, neuroimaging, and biomarkers is essential for accurate diagnosis and may improve early recognition and clinical management.